Society for Endocrinology - a world-leading authority on hormones


Diabetes treatment does not increase risk of bone fracture

18 Jun 2019

According to a recent study in Osteoporosis International, antidiabetic therapies, GLP-1 agonists, SGLT2 inhibitors and DPP-IV inhibitors, do not increase the risk of bone fractures in patients with type 2 diabetes.